Tissue and Cellular Pharmacodynamics of Vascular Growths
Tissue and Cellular Pharmacodynamics of Vascular Growths
批准号:
6718480
负责人:
Elazer R Edelman
金额:
$40.75万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-03-15 至 2006-02-28
关键词:
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Growth factors(GF) control a range of physiological processes in multiple cell types. They should be ideal therapeutic compounds, and yet striking tissue culture and animal model effects become marginal in the clinic. Effective use of vascular GF is challenging principally because their complex structures make them unstable, and the biological parameters they affect are ubiquitous and tightly regulated. Some have explained the difficulty with achieving clinical effect on physicochemical properties. Indeed, it is almost exclusively controlled release that produces positive effects in animal and clinical trials. Initial thoughts were that controlled release circumvented rapid clearance, sustaining release and prolonging receptor-ligand interaction. However, GF with identical physicochemical parameters behave differentially when controlled release, with these differences being accentuated in disease states. Thus, pharmacokinetic clearance alone cannot explain why mode of delivery is so critical to GF biology. Three convergent, interrelated events control the biology of a GF once released to a target tissue and we will progressively examine these events in the normal and diseased tissue states. They include, tissue binding, transport, deposition and distribution of the GF, metabolism, clearance and degradation of the GF, and intercellular communication and signaling. In this revised grant we establish an iterative program which integrates all of these elements by making use of unique tools developed in our laboratory combining aspects of cellular and molecular biology, growth factor biochemistry, materials science, polymer chemistry and controlled-release technology in vitro and in vivo with mathematical modeling. We will specifically: 1 examine the impact of growth factor binding to target tissue under different disease states and after different modes of delivery; 2 define how cellular pharmacokinetics constrains cell-growth factor interactions, 3 characterize the impact on growth factor action of intercellular gap junction signaling; and 4 codify the biological regulatory response to growth factors using mathematical models. The results of these studies will add to our understanding of GF biology and possibly the means by which we develop therapies around these compounds.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Personalized lesion modification optimizes atherosclerosis intervention
-
批准号:10544180
-
项目类别:
-
资助金额:$69.33万
-
财政年份:2022
-
负责人:Elazer R Edelman
-
依托单位:
Personalized lesion modification optimizes atherosclerosis intervention
-
批准号:10346059
-
项目类别:
-
资助金额:$71.39万
-
财政年份:2022
-
负责人:Elazer R Edelman
-
依托单位:
Vascular Drug Delivery
-
批准号:7931349
-
项目类别:
-
资助金额:$16.28万
-
财政年份:2009
-
负责人:Elazer R Edelman
-
依托单位:
Tissue and Cellular Pharmacodynamics of Vascular Growths
-
批准号:6581788
-
项目类别:
-
资助金额:$40.75万
-
财政年份:2003
-
负责人:Elazer R Edelman
-
依托单位:
Tissue and Cellular Pharmacodynamics of Vascular Growths
-
批准号:6856515
-
项目类别:
-
资助金额:$40.75万
-
财政年份:2003
-
负责人:Elazer R Edelman
-
依托单位:
BIOLOGY OF TISSUE ENGINEERED ENDOTHELIAL IMPLANTS
-
批准号:2909315
-
项目类别:
-
资助金额:$37.42万
-
财政年份:1999
-
负责人:Elazer R Edelman
-
依托单位:
BIOLOGY OF TISSUE ENGINEERED ENDOTHELIAL IMPLANTS
-
批准号:6184490
-
项目类别:
-
资助金额:$38.03万
-
财政年份:1999
-
负责人:Elazer R Edelman
-
依托单位:
BIOLOGY OF TISSUE ENGINEERED ENDOTHELIAL IMPLANTS
-
批准号:6537395
-
项目类别:
-
资助金额:$40.35万
-
财政年份:1999
-
负责人:Elazer R Edelman
-
依托单位:
BIOLOGY OF TISSUE ENGINEERED ENDOTHELIAL IMPLANTS
-
批准号:6389930
-
项目类别:
-
资助金额:$39.17万
-
财政年份:1999
-
负责人:Elazer R Edelman
-
依托单位:
PERIVASCULAR DRUG DELIVERY
-
批准号:2186557
-
项目类别:
-
资助金额:$20.81万
-
财政年份:1994
-
负责人:Elazer R Edelman
-
依托单位:
Vascular Drug Delivery
-
批准号:7460481
-
项目类别:
-
资助金额:$41.94万
-
财政年份:1994
-
负责人:Elazer R Edelman
-
依托单位:
Vascular Drug Delivery
-
批准号:8664866
-
项目类别:
-
资助金额:$53.91万
-
财政年份:1994
-
负责人:Elazer R Edelman
-
依托单位:
PERIVASCULAR DRUG DELIVERY
-
批准号:6180144
-
项目类别:
-
资助金额:$32.54万
-
财政年份:1994
-
负责人:Elazer R Edelman
-
依托单位:
PERIVASCULAR DRUG DELIVERY
-
批准号:6018946
-
项目类别:
-
资助金额:$33.62万
-
财政年份:1994
-
负责人:Elazer R Edelman
-
依托单位:
VASCULAR DRUG DELIVERY
-
批准号:6739099
-
项目类别:
-
资助金额:$40.75万
-
财政年份:1994
-
负责人:Elazer R Edelman
-
依托单位:
PERIVASCULAR DRUG DELIVERY
-
批准号:6385797
-
项目类别:
-
资助金额:$41.05万
-
财政年份:1994
-
负责人:Elazer R Edelman
-
依托单位:
PERIVASCULAR DRUG DELIVERY
-
批准号:2459480
-
项目类别:
-
资助金额:$21.65万
-
财政年份:1994
-
负责人:Elazer R Edelman
-
依托单位:
Vascular Drug Delivery
-
批准号:7760942
-
项目类别:
-
资助金额:$41.58万
-
财政年份:1994
-
负责人:Elazer R Edelman
-
依托单位:
Vascular Drug Delivery - Supplement for Equipment
-
批准号:9025113
-
项目类别:
-
资助金额:$11.05万
-
财政年份:1994
-
负责人:Elazer R Edelman
-
依托单位:
VASCULAR DRUG DELIVERY
-
批准号:7035867
-
项目类别:
-
资助金额:$39.79万
-
财政年份:1994
-
负责人:Elazer R Edelman
-
依托单位:
国内基金
海外基金
登录
查看更多内容
RGD-68Ga@AuNCs PET监测PRMT5通过VEGFA调节肺腺癌血管新生的功能及机制
-
批准号:82372007
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:谢文晖
-
依托单位:
PROCR信号通路介导的血管新生在卵巢组织移植中的作用及机制研究
-
批准号:82371726
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:李文
-
依托单位:
RNA编辑型IGFBP7在肿瘤细胞与肿瘤血管微环境中的调控作用及机制研究
-
批准号:32070790
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:徐小燕
-
依托单位:
ROBO4对视网膜血管生成(angiogenesis)的调控及其分子机制
-
批准号:81200692
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:陈凌
-
依托单位:
基于新生血管显像研究MSC治疗缺血性脑血管病的转化医学关键问题
-
批准号:81171370
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:朱朝晖
-
依托单位:
探索VASH2转录激活对肝细胞癌血管生成和上皮间质转化的作用及机制
-
批准号:81172267
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:高文涛
-
依托单位:
解析miR-566调控VHL/β-catenin信号通路影响人脑胶质瘤血管新生的分子机制
-
批准号:81101916
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:周旋
-
依托单位:
脂肪组织来源干细胞促进颗粒脂肪游离移植后再血管化机制的实验研究
-
批准号:81171834
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:鲁峰
-
依托单位:
99mTc-3PRGD2 SPECT显像用于评价肺癌抗新生血管药物疗效的动物研究及肺癌诊断临床研究
-
批准号:81171369
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2011
-
负责人:李方
-
依托单位:
核素靶向示踪肿瘤新生血管作用位点研究
-
批准号:81071183
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2010
-
负责人:王荣福
-
依托单位: